NASDAQ:CYCN

Cyclerion Therapeuticsinc Stock Predictions

Healthcare > Biotechnology

Buy CYCN

*Your capital is at risk

$3.00

-0.0200 (-0.662%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CYCN Prediction Chart

CYCN Predictions History

Latest community submissions for CYCN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
2poJeff Pro	Sep 18, 2019	Bullish	$13.63	X	—	1
StockVader Merchant	Sep 18, 2019	Bullish	$13.63	X	—	1
ILIANA122163	Sep 17, 2019	Bullish	$13.90	X	—	1
JS Pro	Sep 17, 2019	$12.06 -95.66%	$13.90	V	86.76%	0
Chris McGraw @ChrisMcGraw.122145	Sep 17, 2019	Bullish	$13.90	X	—	1
AlexAanderson122142	Sep 17, 2019	Bullish	$13.90	X	—	1
JoeStockTrader	Sep 17, 2019	Bullish	$13.90	X	—	1
StockVader Merchant	Sep 17, 2019	Bullish	$13.90	X	—	1
Rookie	Sep 17, 2019	Bearish	$13.90	V	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CYCN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CYCLERION THERAPEUTICSINC.

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by